Company Filing History:
Years Active: 2001
Title: David Weinberg: Innovator in Pancreatic Cancer Detection
Introduction
David Weinberg is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection and treatment of pancreatic cancer. His innovative work has the potential to improve patient outcomes and advance cancer research.
Latest Patents
David Weinberg holds 1 patent related to methods of identifying and detecting pancreatic cancer. His patent discloses conjugated compounds that comprise a CCK A receptor binding moiety and a radiostable active moiety. Additionally, it includes pharmaceutical compositions that utilize these conjugated compounds for treating individuals suspected of having pancreatic cancer. The patent also outlines methods for radioimaging pancreatic cancer cells and provides in vitro methods, kits, and reagents for determining the presence of pancreatic cancer cells in individuals.
Career Highlights
David Weinberg is affiliated with Thomas Jefferson University, where he continues to engage in groundbreaking research. His work focuses on developing innovative solutions for diagnosing and treating pancreatic cancer, a disease known for its challenging prognosis.
Collaborations
Throughout his career, David has collaborated with esteemed colleagues, including Scott A. Waldman and Michael T. Barber. These partnerships have fostered a collaborative environment that enhances the research and development of effective cancer detection methods.
Conclusion
David Weinberg's contributions to pancreatic cancer detection exemplify the impact of innovation in the medical field. His work not only advances scientific understanding but also holds promise for improving patient care.